Gilead said on Sunday it agreed to acquire cancer-drug company Immunomedics for $US21 billion. Shares of Immunomedic soared as much as 106% on Monday following the news. Immunomedics sells Trodelvy, a drug used to treat different forms of breast cancer and that is being evaluated for a number of other […]

US stocks rose on Friday as traders cheered advances in coronavirus treatment. Gilead Sciences said on Friday that an analysis of clinical-trial data for its remdesivir drug found a 62% reduction in mortality risk among severe COVID-19 patients. Still, the US on Thursday reported 63,200 new coronavirus cases, according to […]

US stocks fluctuated as traders weighed another record spike in virus cases against advances in treatment. On Thursday the US reported 63,200 new coronavirus cases, another record spike, according to data from Johns Hopkins University Meanwhile, Gilead Sciences released clinical-trial data on Friday suggesting its remdesivir treatment reduced COVID-19 mortality […]

The US has struck a deal with Gilead Sciences to purchase more than 90% of the global supply of the drug remdesivir. Remdesivir has been shown to help moderately ill patients recover more quickly from COVID-19, and it is the only proven treatment for the disease. Health and Human Services […]

Leading pharmaceutical companies have seen their combined market capitalizations increase by more than $US50 billion in 2020 as they scramble to develop a vaccine for the coronavirus, according to data compiled by finance blog AksjeBloggen. Gilead Sciences is the frontrunner among six pharma companies, seeing a $US15.7 billion gain in […]

Gilead Sciences on Monday disclosed its pricing for remdesivir, its coronavirus-fighting drug. Shares of the company jumped as much as 4% in premarket trading. The company will charge the US government and developed countries $US390 per vial of remdesivir, or $US2,340 for a five-day course using six vials of the […]

Hello, Welcome to Dispensed Daily, your daily dose of healthcare news from Business Insider. New to the newsletter? You can sign up here to get this email in your inbox every day. Let’s dive into today’s top stories from the healthcare team. The presentation digital health startup Cedar used in […]

The biotech giant that developed the first effective coronavirus treatment is now looking to expand its impact. Gilead Sciences CEO Daniel O’Day said Monday that the company would start testing an inhaled version of the antiviral drug remdesivir in August. Currently, the drug is given as an intravenous infusion. If […]

The federal government on Saturday announced initial plans for distributing a promising coronavirus drug, remdesivir. The drug, manufactured by Gilead Sciences, was authorised for emergency use last week, but doctors and hospitals weren’t sure how they were going to get it. The Department of Health and Human Services now say […]

Gilead Sciences could be justified in charging up to $US4,500 per coronavirus patient for its drug, a nonprofit pricing watchdog said in a recent report. The California biotech is the maker of remdesivir, an experimental antiviral treatment that helped hospitalized COVID-19 patients recover 31% faster, shaving four days off hospital […]

Hello, Welcome to Dispensed, Business Insider’s weekly healthcare newsletter, in which we’re contemplating how it could possibly already be May. I looked at my calendar this morning and calculated that I’ve been doing this work-from-home/social distancing thing for 51 days here in Brooklyn. Outside, New York is planning out how […]

Scientists are racing to find ways to prevent and treat the novel coronavirus. That includes developing vaccines to prevent the disease, as well as testing out new or repurposed medications in the hopes that they might help patients severely ill with COVID-19, the disease caused by the novel coronavirus, recover. […]

A leading coronavirus treatment candidate has succeeded in a critical trial, helping severe COVID-19 patients recover faster. A new study of more than 1,000 hospitalized patients found that those taking the antiviral drug remdesivir recovered 31% faster than those taking a placebo, the US National Institutes of Health said Wednesday. […]

Hello, Welcome to Dispensed, Business Insider’s weekly healthcare newsletter. How are you all? Can you believe we’ve been doing this for more than a month by now? This week, the healthcare team here at BI has stayed busy keeping tabs on the latest efforts to reopen parts of the country […]

The World Health Organisation accidentally posted a summary of study results finding that a leading experimental coronavirus treatment did not help a group of patients with severe cases, according to reports from the Financial Times and STAT News. A WHO representative confirmed the mistake, saying that the summary was quickly […]

Gilead’s experimental coronavirus treatment has a 50/50 chance at gaining approval at best, RBC Capital Markets analysts wrote Wednesday. The biotech company soared amid the late February downturn after a World Health Organisation official deemed its remdesivir compound the best bet yet to combat the epidemic. Though the drug’s success […]

Gilead Sciences on Monday said it plans to buy cancer-drug maker Forty Seven in a $US4.9 billion deal. The news sent Forty Seven’s stock up as much as 62% during regular trading. The deal is the latest to add to Gilead’s presence in cancer immunotherapy, an approach to treating cancer […]